These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 22868003

  • 1. Hyperhaploid plasma cell myeloma.
    Hoctor VT, Campbell LJ.
    Cancer Genet; 2012; 205(7-8):414-8. PubMed ID: 22868003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytogenetics of multiple myeloma.
    Trcić RL, Skelin IK, Sustercić D, Planinc-Peraica A, Ajduković R, Haris V, Kusec R, Begović D.
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F, Pedrazzini E, Rodríguez A, Baialardo E, Kusminsky G, Arbelbide J, Fantl DB, Slavutsky I.
    Cytogenet Genome Res; 2011 Mar; 134(4):249-59. PubMed ID: 21734361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
    Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Dávila R, González-Paz N, Winkler JM, Kyle RA, Gertz MA, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA, Greipp PR, Fonseca R.
    Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
    [Abstract] [Full Text] [Related]

  • 12. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D, San Miguel JF, Garcia-Sanz M, Nájera L, García-Isidoro M, Peréz-Simon JA, Gonzalez M, Wiegant J, Raap AK, Orfão A.
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
    Lange K, Gadzicki D, Schlegelberger B, Göhring G.
    Leuk Res; 2010 Aug; 34(8):1002-6. PubMed ID: 20022374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M.
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic manifestations of multiple myeloma heterogeneity.
    Pantou D, Rizou H, Tsarouha H, Pouli A, Papanastasiou K, Stamatellou M, Trangas T, Pandis N, Bardi G.
    Genes Chromosomes Cancer; 2005 Jan; 42(1):44-57. PubMed ID: 15495197
    [Abstract] [Full Text] [Related]

  • 19. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
    Scudla V, Jarosová M, Kapustová M, Indrák K, Smoldas J.
    Acta Univ Palacki Olomuc Fac Med; 1991 Jan; 129():69-79. PubMed ID: 1837676
    [Abstract] [Full Text] [Related]

  • 20. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL, Beverloo B, Velthuizen SJ, Sonneveld P.
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.